| Schedule of Long-Term Debt Instruments |
The Company’s outstanding debt obligations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
|
Aggregate
Principal
Committed |
|
|
Outstanding
Principal |
|
|
Unused
Portion |
|
|
Aggregate
Principal
Committed |
|
|
Outstanding
Principal |
|
|
Unused
Portion |
|
Barclays Funding Facility(1) |
$ |
600,000 |
|
|
$ |
449,055 |
|
|
$ |
150,945 |
|
|
$ |
600,000 |
|
|
$ |
452,199 |
|
|
$ |
147,801 |
|
BNP Funding Facility |
|
500,000 |
|
|
|
240,000 |
|
|
|
260,000 |
|
|
|
500,000 |
|
|
|
227,000 |
|
|
|
273,000 |
|
JPM Funding Facility(2) |
|
500,000 |
|
|
|
377,730 |
|
|
|
122,270 |
|
|
|
500,000 |
|
|
|
433,759 |
|
|
|
66,241 |
|
Total |
$ |
1,600,000 |
|
|
$ |
1,066,785 |
|
|
$ |
533,215 |
|
|
$ |
1,600,000 |
|
|
$ |
1,112,958 |
|
|
$ |
487,042 |
|
(1)Under the Barclays Funding Facility, the Company may borrow in U.S. dollars or certain other permitted currencies. As of June 30, 2026 and December 31, 2025, the Company had borrowings denominated in Euros (EUR) of 0 and 6,555, respectively. (2)Under the JPM Funding Facility, the Company may borrow in U.S. dollars or certain other permitted currencies. As of June 30, 2026 and December 31, 2025, the Company had borrowings denominated in Canadian Dollars (CAD) of 350 and 350, Euros (EUR) of 557 and 557, and British Pound Sterling (GBP) of 186 and 186, respectively. The Company's summary information of its debt obligations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Combined weighted average interest rate (1) |
|
5.65 |
% |
|
|
6.54 |
% |
|
|
5.65 |
% |
|
|
6.60 |
% |
Combined weighted average effective interest rate (2) |
|
5.98 |
% |
|
|
6.88 |
% |
|
|
5.97 |
% |
|
|
6.94 |
% |
Combined weighted average debt outstanding |
$ |
1,083,569 |
|
|
$ |
1,008,273 |
|
|
$ |
1,095,445 |
|
|
$ |
1,017,136 |
|
(1)Excludes unused fees and financing costs. The summary information of the CBA Subscription Facility is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Borrowing interest expense |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
68 |
|
Facility unused commitment fees |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
36 |
|
Amortization of deferred financing costs |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
66 |
|
Total |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
170 |
|
Weighted average interest rate |
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
|
6.36 |
% |
Weighted average effective interest rate |
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
|
6.30 |
% |
Weighted average outstanding balance |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,095 |
|
(1)For the six months ended June 30, 2025, calculated for the period from December 31, 2024 through March 4, 2025 (termination date). The summary information of the Barclays Funding Facility is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Borrowing interest expense |
$ |
6,363 |
|
|
$ |
7,372 |
|
|
$ |
12,620 |
|
|
$ |
14,780 |
|
Facility unused commitment fees |
|
191 |
|
|
|
188 |
|
|
|
376 |
|
|
|
375 |
|
Amortization of deferred financing costs |
|
322 |
|
|
|
295 |
|
|
|
640 |
|
|
|
586 |
|
Total |
$ |
6,876 |
|
|
$ |
7,855 |
|
|
$ |
13,636 |
|
|
$ |
15,741 |
|
Weighted average interest rate |
|
5.59 |
% |
|
|
6.46 |
% |
|
|
5.57 |
% |
|
|
6.52 |
% |
Weighted average effective interest rate |
|
5.87 |
% |
|
|
6.72 |
% |
|
|
5.85 |
% |
|
|
6.77 |
% |
Weighted average outstanding balance |
$ |
450,474 |
|
|
$ |
451,288 |
|
|
$ |
450,879 |
|
|
$ |
451,144 |
|
The summary information of the BNP Funding Facility is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Borrowing interest expense |
$ |
3,800 |
|
|
$ |
3,219 |
|
|
$ |
7,136 |
|
|
$ |
6,753 |
|
Facility unused commitment fees |
|
424 |
|
|
|
656 |
|
|
|
955 |
|
|
|
963 |
|
Amortization of deferred financing costs |
|
267 |
|
|
|
246 |
|
|
|
526 |
|
|
|
490 |
|
Total |
$ |
4,491 |
|
|
$ |
4,121 |
|
|
$ |
8,617 |
|
|
$ |
8,206 |
|
Weighted average interest rate |
|
5.89 |
% |
|
|
6.57 |
% |
|
|
5.91 |
% |
|
|
6.58 |
% |
Weighted average effective interest rate |
|
6.31 |
% |
|
|
7.08 |
% |
|
|
6.35 |
% |
|
|
7.05 |
% |
Weighted average outstanding balance |
$ |
255,011 |
|
|
$ |
193,714 |
|
|
$ |
240,077 |
|
|
$ |
204,282 |
|
The summary information of the JPM Funding Facility is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Borrowing interest expense |
$ |
5,311 |
|
|
$ |
6,085 |
|
|
$ |
11,336 |
|
|
$ |
12,140 |
|
Facility unused commitment fees |
|
169 |
|
|
|
250 |
|
|
|
264 |
|
|
|
541 |
|
Amortization of deferred financing costs |
|
309 |
|
|
|
307 |
|
|
|
614 |
|
|
|
610 |
|
Total |
$ |
5,789 |
|
|
$ |
6,642 |
|
|
$ |
12,214 |
|
|
$ |
13,291 |
|
Weighted average interest rate |
|
5.56 |
% |
|
|
6.63 |
% |
|
|
5.57 |
% |
|
|
6.71 |
% |
Weighted average effective interest rate |
|
5.88 |
% |
|
|
6.96 |
% |
|
|
5.88 |
% |
|
|
7.05 |
% |
Weighted average outstanding balance |
$ |
378,084 |
|
|
$ |
363,271 |
|
|
$ |
404,489 |
|
|
$ |
359,589 |
|
|